Lumito AB (publ) LUMITO

Updated: 12 Aug 2026

NGM | Biotech | Medical technology / Digital pathology

No signal published yet

We already track Lumito and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Lumito free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NGM
Type
Biotech
Sector
Medical technology / Digital pathology
We're already tracking Lumito AB (publ) — here are the latest events we've registered

Recent News

  • On August 10, 2026, Lumito's board resolved on a directed issue of units to guarantors following the completion of its rights issue. The capital raise was carried out during summer 2026 to strengthen the cash position and accelerate commercialization.

What Firelda Watch includes for Lumito AB (publ)

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Lumito AB (publ) will be delivered in the same format.

Want to follow Lumito AB (publ)? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Lumito free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Lumito AB (publ) LUMITO
Lumito — follow and we'll monitor it
Follow Lumito free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.